Healthtech Startups

Ludocare develops digital therapeutics for pediatric asthma management, combining an interactive health companion app for children with a parental app for monitoring and treatment optimization. The company targets healthcare systems and pediatricians in France seeking to improve asthma control and medication adherence in children ages 4-11.

1 investor

Lully develops an under-mattress device that uses timed vibrations to prevent night terrors in children. The company applies clinical sleep science and user research to create products addressing sleep problems in pediatric populations.

1 investor

Lumara provides AI agents that automate administrative tasks for healthcare organizations, helping health plans, digital health companies, and other healthcare ecosystem players reduce operational costs while improving member engagement and experience.

1 investor

Lume provides a platform that integrates coaching, health insights, and data systems to support founder performance and well-being. The platform serves founders building startups, combining professional coaching and health optimization to improve sustainable high performance.

1 investor

Lume provided a mobile banking platform for nurses that offered earned wage access, student loan refinancing, and job placement services for travel nursing positions.

1 investor

Lume develops a wearable sweat sensor that monitors hormonal changes and health metrics throughout the day. The device is designed for individuals seeking continuous health insights beyond traditional periodic checkups.

1 investor

Lumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.

1 investor

Lumena Pharmaceuticals develops pharmaceutical, nutraceutical, and testing service products using biotechnology, with a focus on ethical practices in research, manufacturing, and distribution across health care markets. The company prioritizes environmental sustainability, reduced chemical use, and responsible innovation in bioavailable product development.

1 investor

Lumenis develops and commercializes energy-based medical devices for the aesthetics and vision markets, serving healthcare professionals worldwide. The company holds over 330 patents and numerous FDA clearances, with an installed base of more than 80,000 systems across over 100 countries.

1 investor

Lumeria makes the Lumoscope, a multi-spectrum skin imaging scanner that clips onto a phone and uses RGB, UV, and polarized light to track skin conditions such as fine lines, tone, texture, pigment, and vascularity. Paired with an AI assistant called Lumi, it offers consumers personalized skincare routines, ingredient analysis, and progress tracking for at-home skin monitoring (not medical diagnosis).

1 investor

InvolveXR offers an AI-enabled virtual reality training platform for healthcare education that combines immersive simulations with AI-assisted assessments to help institutions scale personalized learning and clinical skill development.

1 investor

LUMEUS develops digital mental health training programs based on the Herzog Method for children and adults, offering emotional wellness and stress management courses delivered through an app and online platform.

1 investor

Lumia Care operates a healthcare conglomerate that provides aged care, disability support, hospital-level in-home care, and nursing workforce services across Australia. The company serves individuals, families, and healthcare institutions seeking personalized and clinical care services to support independence and wellbeing.

1 investor

Luminary Therapeutics is a clinical-stage biotech developing allogeneic CAR-T cell therapies built on its Gamma 2.0+ platform to treat solid tumors, B-cell malignancies, and B-cell-mediated autoimmune diseases. The company uses a Dual CAR architecture and the TcBuster transposon system to address relapse, T cell exhaustion, and high manufacturing costs.

1 investor

Luminist Labs provided a non-invasive test to identify and assess the progression of liver fibrosis and NASH in patients. The company was acquired by DiscernDx in 2020.

1 investor

Luminoah is a medical technology company developing a connected enteral nutrition (tube feeding) system that combines a compact smart pump with a mobile app to track feeding data. Its products serve individuals who rely on tube feeding, along with their caregivers and clinicians.

1 investor

Lumius develops a 3D ultrasound device designed to provide fast, smart, and accessible imaging capabilities. The device functions as a 3D camera for internal body visualization, serving the medical imaging market.

1 investor

Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.

1 investor

Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.

1 investor

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.

1 investor

Lumos develops light-emitting glasses that project turquoise-blue 480nm light to activate melanopsin, paired with sensors that track melanopic light exposure and usage time via a companion app for personalized insights and clinician integration. The product combines a nano coating that reflects melanopic light and biology-emulating light sensors within a wearable device.

1 investor

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency. It also pursues partnerships to in-license or acquire additional rare disease therapeutic candidates for development and commercialization.

1 investor

Luna is a home-based physical therapy service that connects patients with licensed physical therapists for in-person treatment at their home or workplace, supported by an app for exercise prescription and communication between sessions.

1 investor

LUNAC Therapeutics develops first-in-class oral and intravenous anticoagulants targeting activated Factor XII to treat and prevent thrombotic events with reduced bleeding risk. The company focuses on cardiovascular and blood coagulation therapies for patients requiring anticoagulation.

1 investor